Lynx Investment Advisory Merck & Co., Inc. Transaction History
Lynx Investment Advisory
- $139 Billion
- Q3 2024
A detailed history of Lynx Investment Advisory transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lynx Investment Advisory holds 2,929 shares of MRK stock, worth $292,021. This represents 0.24% of its overall portfolio holdings.
Number of Shares
2,929
Previous 2,260
29.6%
Holding current value
$292,021
Previous $280 Million
18.89%
% of portfolio
0.24%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.9 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.9 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.56 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.9 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $253B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...